INVO Fertility, Inc. (IVF)

INVO Fertility Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023
Revenue	6.59	6.53	3.02
Revenue Growth (YoY)	-	116.25%	-
Cost of Revenue	3.85	3.66	1.93
Gross Profit	2.74	2.87	1.09
Selling, General & Admin	10.19	9.08	7.49
Research & Development	0.75	0.49	0.17
Operating Expenses	11.87	10.49	7.85
Operating Income	-9.13	-7.61	-6.77
Interest Expense	-1.19	-1.06	-0.93
Currency Exchange Gain (Loss)	-	-	-0
EBT Excluding Unusual Items	-10.4	-8.67	-7.69
Gain (Loss) on Sale of Investments	0.01	0.01	-0.15
Gain (Loss) on Sale of Assets	0.05	-0.51	-
Other Unusual Items	0.05	0.05	-0.16
Pretax Income	-24.93	-9.12	-8.01
Income Tax Expense	-0.02	-0.02	0.03
Net Income	-24.9	-9.1	-8.03
Preferred Dividends & Other Adjustments	0.25	0.25	-
Net Income to Common	-25.15	-9.35	-8.03
Shares Outstanding (Basic)	0	0	0
Shares Outstanding (Diluted)	0	0	0
Shares Change (YoY)	-	159.54%	-
EPS (Basic)	-124.94	-90.58	-202.10
EPS (Diluted)	-124.95	-90.58	-202.11
Free Cash Flow	-6.41	-3.16	-5.2
Free Cash Flow Per Share	-31.83	-30.61	-130.80
Gross Margin	41.57%	44.00%	35.96%
Operating Margin	-138.48%	-116.56%	-224.03%
Profit Margin	-381.52%	-143.09%	-266.00%
Free Cash Flow Margin	-97.20%	-48.35%	-172.14%
EBITDA	-8.2	-6.69	-6.57
EBITDA Margin	-124.42%	-102.48%	-217.38%
D&A For EBITDA	0.93	0.92	0.2
EBIT	-9.13	-7.61	-6.77
EBIT Margin	-138.48%	-116.56%	-224.03%
Revenue as Reported	6.59	6.53	3.02

Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q